• Structural Advances in Silybin Chemistry from Milk Thistle E

  2026-07-14

  Křen et al.'s comprehensive review elucidates the structural complexity, stereochemistry, and derivatization of silybin, the principal flavonolignan in milk thistle extract. These insights underpin the rational use of silymarin in oxidative stress, cancer, and metabolic research, supporting the optimization of experimental protocols and compound selection.

• Gamithromycin (BA1074): Reliable Solutions for Respiratory P

  2026-07-14

  This article presents a scenario-driven, evidence-based exploration of Gamithromycin (SKU BA1074) for researchers conducting cell viability and respiratory infection assays. Drawing on peer-reviewed studies and validated protocols, it highlights how Gamithromycin's PK/PD properties and formulation enable reproducible, data-rich results in challenging laboratory workflows. Practical Q&A blocks address common pain points, ensuring that scientists can confidently select and deploy this macrolide antibiotic in translational research.

• Microsecond Pulsed Electric Fields Drive Cardiomyocyte Ablat

  2026-07-13

  This study demonstrates that microsecond pulsed electric fields (μsPEFs) induce targeted myocardial ablation by disrupting mitochondria and triggering cell death in cardiomyocytes. The findings refine mechanistic understanding and establish quantitative parameters for effective, non-thermal cardiac ablation, offering crucial guidance for translational research and therapeutic innovation.

• T7 RNA Polymerase: Precision Tools for RNA Synthesis and LNP

  2026-07-13

  Explore the unique capabilities of T7 RNA Polymerase, a recombinant enzyme expressed in E. coli, for advanced RNA synthesis and in vitro transcription. Discover how recent breakthroughs in lipid nanoparticle trafficking inform practical assay design and elevate RNA-based research.

• Arachidonic Acid Enhances Humoral Immunity Post-Vaccination

  2026-07-12

  The reference study demonstrates that dietary arachidonic acid (ARA) supplementation significantly accelerates and amplifies neutralizing antibody responses following rabies vaccination in mice and humans. By elucidating a novel PGI2-mediated pathway for B cell activation, this work proposes ARA as a promising dietary adjuvant to improve vaccine efficacy and rapid immune protection.

• SMPD4-Mediated Sphingolipid Metabolism in Brain and Cilia De

  2026-07-10

  This study uncovers how SMPD4-driven ceramide production is essential for human brain and primary cilia development. By integrating mouse models and human iPSC systems, the researchers establish a mechanistic link between sphingolipid metabolism, neural progenitor survival, and major neurodevelopmental disorders.

• Polybrene (Hexadimethrine Bromide) 10 mg/mL: Precision for C

  2026-07-09

  This article examines real-world laboratory challenges and evidence-based solutions provided by Polybrene (Hexadimethrine Bromide) 10 mg/mL (SKU K2701). Through scenario-driven Q&A, it addresses reproducibility, assay sensitivity, and workflow optimization for gene transduction and transfection. Researchers will gain practical, validated best practices for leveraging SKU K2701 in demanding cellular assays.

• Selective Spectrophotometric Determination of β-Lactam Antib

  2026-07-09

  This study introduces two optimized spectrophotometric methods for the selective quantification of phenolic β-lactam antibiotics, including combinations with dicloxacillin, in pure and formulated samples. The protocols offer a practical advance for routine quality control and address analytical gaps left by standard chromatographic techniques.

• Plerixafor (AMD3100): CXCR4 Inhibition for Cancer and Stem C

  2026-07-08

  Plerixafor (AMD3100) is a potent CXCR4 inhibitor used in cancer metastasis and hematopoietic stem cell mobilization research. Its high specificity and well-characterized action make it a benchmark reagent for dissecting the CXCL12/CXCR4 axis in oncology and immunology. APExBIO supplies validated Plerixafor (A2025) for reproducible experimental workflows.

• Trelagliptin Succinate: Novel Insights Beyond Glycemic Contr

  2026-07-08

  Explore Trelagliptin succinate’s multifaceted mechanism, including its emerging role in osteoblastic differentiation and diabetes mellitus research. This article goes beyond standard protocols to reveal practical, reference-backed assay implications.

• Icatibant’s Role in Hantavirus and COVID-19: Clinical Insigh

  2026-07-07

  This article examines the clinical innovation of using icatibant, a bradykinin receptor antagonist, in the management of severe viral infections such as nephropathia epidemica (NE) and COVID-19. The reference study highlights its mechanistic rationale, patient outcomes, and the significance for future translational infection research.

• Toxicological Profile of Decitabine in Murine Antileukemic M

  2026-07-07

  This study by Momparler & Frith systematically characterizes the acute and reversible toxic effects of Decitabine (5-Aza-2'-deoxycytidine) in mice, providing foundational data for its clinical translation in hematopoietic malignancy research. The findings inform both dosage safety and mechanistic understanding critical for cancer epigenetics workflows.

• Redefining In Vitro Drug Response Evaluation in Cancer Resea

  2026-07-06

  Schwartz's dissertation introduces a nuanced framework for evaluating anticancer drug effects in vitro, distinguishing between proliferative arrest and cell death. These insights offer researchers a more accurate understanding of drug mechanisms, informing both assay design and translational relevance.

• Streptavidin-FITC: Precision Biotin Detection for Advanced W

  2026-07-06

  Streptavidin-FITC enables ultrasensitive, quantitative detection of biotinylated molecules in immunofluorescence, flow cytometry, and nanoparticle trafficking studies. Its high-affinity binding and robust fluorescence empower researchers to tackle complex intracellular assays with confidence and reproducibility.

• Podophyllotoxin: Mechanistic Leverage for Overcoming Cancer

  2026-07-05

  Podophyllotoxin’s dual action as a microtubule inhibitor and apoptosis inducer is reshaping strategies in anticancer drug research, particularly in the context of multidrug resistance (MDR). This thought-leadership article provides translational researchers with mechanistic insights, protocol guidance, and a strategic vision for leveraging podophyllotoxin and its derivatives in high-impact oncology studies. Integrating recent findings and established workflows, we explore how APExBIO’s podophyllotoxin (SKU N1790) empowers reproducibility and innovation in cell cycle, autophagy, and hepatocellular carcinoma models.

16414 records 1/1095 page Next 12345 下5页 Last page